Takeda Pharmaceutical Company Limited | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Headlines Articles Press releases Takeda Pharmaceutical Company Limited

Home
Companies
Takeda Pharmaceutical Company Limited

BRIEF

published on 10/31/2024 at 07:05, 21 days 2 hours ago

Takeda Revises FY2024 Financial Forecasts

Net Profit Growth Operating Profit Increase Takeda Financial Forecast FY2024 Revisions VYVANSE Impact
BRIEF

published on 10/31/2024 at 07:05, 21 days 2 hours ago

Takeda révise ses prévisions financières pour l'exercice 2024

Croissance Du Bénéfice Net Prévisions Financières De Takeda Révisions Pour L'exercice 2024 L'impact De VYVANSE Augmentation Du Résultat D'exploitation
PRESS RELEASE

published on 10/31/2024 at 07:00, 21 days 2 hours ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical revises FY2024 financial forecast, expecting growth in revenue and profit. Core metrics show positive trends. Details on the forecast and reasons for revision provided

Financials FY2024 Revised Forecast Takeda Pharmaceutical Core Metrics
BRIEF

published on 05/09/2024 at 08:05, 6 months 12 days ago

Takeda Launches Major Program to Boost Growth and Enhance Profit Margins

Takeda Pharmaceutical Growth Profit Margin Improvement Digital Investment Restructuring Costs
BRIEF

published on 05/09/2024 at 08:05, 6 months 12 days ago

Takeda lance un programme majeur pour stimuler la croissance et améliorer les marges bénéficiaires

Takeda Croissance Pharmaceutique Amélioration De La Marge Bénéficiaire Investissement Numérique Coûts De Restructuration
PRESS RELEASE

published on 05/09/2024 at 08:00, 6 months 12 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
Takeda announces enterprise-wide program to support growth and deliver core operating profit margin improvement, focusing on organizational agility and leveraging data, digital, and technology capabilities

Takeda Pharmaceutical Company Limited Enterprise-wide Program Core Operating Profit Margin Organizational Agility Data Digital Technology
PRESS RELEASE

published on 10/26/2023 at 08:00, 1 year ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)

Accesswire

Published on 11/21/2024 at 09:00, 58 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 23 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 33 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 58 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 58 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 17 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 57 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 58 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 58 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 43 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 50 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 38 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE